Mark Peterson

HRC Fertility earns top honors by pioneering needle-free IVF, challenging outdated medical terms, and focusing on the human side of a complex journey.

A new partnership aims to end fragmented employee benefits, offering a single, unified platform to support working families through complex care needs.

Czech MedTech firm Stimvia builds a scientific and commercial 'dream team' to launch its non-invasive URIS® therapy for overactive bladder worldwide.

The surgical robotics market is set to double by 2030, fueling a high-stakes battle between giants and a critical race for supply chain innovation.

True crime titans unite as Hunt A Killer and Morbid launch an immersive game, letting fans solve a cold case with physical clues and exclusive audio.

A new search platform, AnySearch, aims to revolutionize AI by giving agents access to the high-value, hidden data that traditional search engines miss.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A landmark European trial for a new genomic test has passed 50% recruitment, promising to tailor breast cancer therapy and improve patient quality of life.

C1Secure's new tool extends ServiceNow's AI Control Tower, giving enterprises real-time economic and productivity insights into their AI investments.

At 30, Natalie Rodriguez is one of South Florida's youngest hospital CEOs. Her mission: rebuild trust and deepen community ties at Coral Gables Hospital.

A new survey reveals modern renters demand affordability, location, and freedom, fueling a coliving boom that is disrupting the traditional housing market.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

A new FDA-cleared system offers hope against postpartum hemorrhage, the leading cause of maternal death, earning its maker a prestigious Edison Award.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

The clean energy vehicle company is assembling a top-tier team to develop hydrogen-powered drones, aiming for a slice of the $182 billion UGV market.

A novel medical food for IBS shows remarkable efficacy in new studies, exceeding FDA benchmarks for pain relief and solving the long-standing issue of taste.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

As demand for complex medical flights soars, a specialized industry of 'flying ICUs' navigates immense logistical and medical hurdles to save lives.

A new app for cleaning gravestones just won a major industry award. See how AI and a national network are changing how we care for departed loved ones.